Dr. Edwin C. Kingsley

Dr. Edwin C. Kingsley, MD, is a board-certified medical oncologist recognized for his expertise in gastrointestinal cancers and his leadership in community-based oncology research. He is a founding partner of Illinois CancerCare, where he has expanded access to cutting-edge cancer treatments through extensive participation in clinical trials. Dr. Kingsley earned his medical degree from Rush Medical College, completed his residency in internal medicine at Loyola University Medical Center, and received his fellowship training in hematology and oncology at the University of Minnesota. He is committed to bringing innovative therapies to patients in community settings while maintaining the highest standards of personalized care.

Dr. Kingsley’s clinical and research work focuses on colorectal, pancreatic, and hepatobiliary cancers, with an emphasis on integrating novel targeted agents, immunotherapies, and advanced chemotherapy regimens into treatment plans. He has served as principal investigator on numerous cooperative group and industry-sponsored trials, contributing to pivotal studies that have defined current standards of care in gastrointestinal oncology. His approach emphasizes translational research that moves promising treatments from academic centers into community practice, expanding their real-world impact.

Beyond his research achievements, Dr. Kingsley is deeply involved in patient advocacy and professional education. He is an active member of the American Society of Clinical Oncology (ASCO) and the Eastern Cooperative Oncology Group (ECOG), where he participates in protocol development and scientific review committees. Through his dedication to advancing clinical research and expanding patient access to novel therapies, Dr. Edwin C. Kingsley continues to make a significant impact on the treatment of gastrointestinal cancers.